Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
AXL Inhibition Enhances MEK Inhibitor Sensitivity in Malignant Peripheral Nerve Sheath Tumors.
Journal: Journal of cancer science and clinical therapeutics
Published: December 07, 2020
Clinical Observations and Molecular Variables of Primary Vascular Leiomyosarcoma.
Journal: JAMA surgery
Published: December 03, 2015
Progressive loss of myogenic differentiation in leiomyosarcoma has prognostic value.
Journal: Histopathology
Published: April 26, 2014
Uterine leiomyosarcoma management, outcome, and associated molecular biomarkers: a single institution's experience.
Journal: Annals of surgical oncology
Published: August 14, 2012
Targeting the PI3K/mTOR axis, alone and in combination with autophagy blockade, for the treatment of malignant peripheral nerve sheath tumors.
Journal: Molecular cancer therapeutics
Published: August 01, 2012
Dual targeting of mTOR and aurora-A kinase for the treatment of uterine Leiomyosarcoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 24, 2012
Localized and metastatic myxoid/round cell liposarcoma: clinical and molecular observations.
Journal: Cancer
Published: June 09, 2012
FAP-related desmoid tumors: a series of 44 patients evaluated in a cancer referral center.
Journal: Histology and histopathology
Published: March 16, 2012
Survivin is a viable target for the treatment of malignant peripheral nerve sheath tumors.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 13, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026